Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Clinical, Molecular, and Prognostic Comparisons between Clonal Cytopenias of Undetermined Significance and Lower-Risk Myelodysplastic Syndromes - a Study of 184 Molecularly Annotated Patients

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-134963

Published: 2020

Journal Articles

Spectrum of Abnormalities and Clonal Transformation in Germline RUNX1 Familial Platelet Disorder and a Comparative Analysis with Somatic RUNX1 Mutations in Myeloid Neoplasms

Emma Difilippo, BS, Giacomo Coltro, MD, Ryan M. Carr, MD PhD, Abhishek A Mangaonkar, MBBS, Moritz Binder, MDMPH, Shakila P Khan, MD, Vilmarie Rodriguez, MD, Naseema Gangat, MBBS, Alexandra Wolanskyj, MD, Rajiv K. Pruthi, MBBS, Dong Chen, MD PhD, Rong He, MD, David S Viswanatha, MD, Terra Lasho, PhD, Christy Finke, BS, Ayalew Tefferi, MD, Animesh Pardanani, MBBS, PhD, Mark Litzow, MD, Mrinal M Patnaik, MDMBBS

Blood (2019) 134 (Supplement_1): 3003.

https://doi.org/10.1182/blood-2019-124830

Published: 2019

Journal Articles

Desideromastica: Tactile Chew Cravings in Iron Deficiency Anemia

Caleb J Scheckel, DO, Didar Yanardag Acik, MD, Aneel A. Ashrani, MD MS, C. Christopher Hook, MD, Lindsey Ann Kluck, APRN, CNP, MSN, Ariela L. Marshall, MD, Rajiv K. Pruthi, MBBS, Aishwarya Ravindran, MBBS, Mithun Vinod Shah, MD PhD, Alexandra Wolanskyj, MD, Ronald S. Go, MD

Blood (2019) 134 (Supplement_1): 4815.

https://doi.org/10.1182/blood-2019-127306

Published: 2019

Journal Articles

3,023 Mayo Clinic Patients with Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

Natasha Szuber, MD, Mythri Mudireddy, MBBS, Maura Nicolosi, MD, Domenico Penna, MD, Rangit Vallapureddy, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Kebede H. Begna, MD, Michelle A. Elliott, MD, C. Christopher Hook, MD, Alexandra Wolanskyj, MD, Mrinal M. Patnaik, MD MBBS, Curtis A. Hanson, MD, Rhett P. Ketterling, Shireen Sirhan, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Lambert Busque, MD, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 3035.

https://doi.org/10.1182/blood-2018-99-109740

Published: 2018

Journal Articles

The Clinical Utility of Pharmacogenomics Testing in Assessing Tyrosine Kinase Inhibitor Therapy, Intolerance and Responses in Patients with Chronic Myelogenous Leukemia

Blood (2018) 132 (Supplement 1): 5440.

https://doi.org/10.1182/blood-2018-99-118600

Published: 2018

Journal Articles

Decreased Survival and Increased Rate of Fibrotic Progression in Essential Thrombocythemia Chronicled after the FDA Approval Date of Anagrelide

Ayalew Tefferi, MD, Natasha Szuber, MD, Kebede H. Begna, MD, Mrinal M. Patnaik, MD MBBS, Michelle A. Elliott, MD, C. Christopher Hook, MD, Alexandra Wolanskyj, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS

Blood (2018) 132 (Supplement 1): 4287.

https://doi.org/10.1182/blood-2018-99-116601

Published: 2018

Journal Articles

1,123 Consecutive Adults with Non-APL Acute Myeloid Leukemia: The Mayo Clinic Experience

Kebede H. Begna, MD, Walid Ali, MD, Naseema Gangat, MBBS, Michelle A. Elliott, MD, Aref Al-Kali, MD, Mark R. Litzow, MD, C. Christopher Hook, MD, Alexandra Wolanskyj, MD, William J. Hogan, MBBCh, Mrinal M. Patnaik, MD MBBS, Animesh Pardanani, MBBS, PhD, Darci Zblewski, APRN, C-NP, Dong Chen, MD PhD, Rong He, MD, David S Viswanatha, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, Ayalew Tefferi, MD

Blood (2018) 132 (Supplement 1): 2689.

https://doi.org/10.1182/blood-2018-99-110811

Published: 2018

Journal Articles

Prognostic Impact of ASXL1 Mutations and Extent of Bone Marrow Dysplasia in Patients with Who - defined Myelodysplastic Syndrome with Ring Sideroblasts

Abhishek Mangaonkar, MD, Terra L. Lasho, PhD, Christy Finke, BS, Naseema Gangat, MBBS, Aref Al-Kali, MD, Michelle A. Elliott, MD, Kebede H. Begna, MD, Hassan Alkhateeb, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Alexandra Wolanskyj, MD, William J. Hogan, MBBCh, Animesh Pardanani, MBBS PhD, Mark R. Litzow, MD, Ayalew Tefferi, MD, Mrinal M. Patnaik, MDMBBS

Blood (2017) 130 (Supplement 1): 2971.

https://doi.org/10.1182/blood.V130.Suppl_1.2971.2971

Published: 2017

Journal Articles

Analysis of Serum Ferritin Levels As a Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis (HLH) in Hospitalized Adult Patients

Anthony Q Pham, MD, Megan M. O'Byrne, Prashant Kapoor, MD, Mithun Vinod Shah, MD PhD, Roshini S Abraham, PhD, Ronald S. Go, MD, Alexandra Wolanskyj, MD, Sameer A. Parikh, MD

Blood (2015) 126 (23): 1014.

https://doi.org/10.1182/blood.V126.23.1014.1014

Published: 2015

Journal Articles

Survival Trends in Essential Thrombocythemia in the Face of Changing Treatment Practices

A Kamel Abou Hussein, MD, Naseema Gangat, MBBS, Yoseph Elala, MD, Alexandra Wolanskyj, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2015) 126 (23): 2805.

https://doi.org/10.1182/blood.V126.23.2805.2805

Published: 2015

Journal Articles

Clinico-Pathological Features and Outcomes in Patients with Congenital Sideroblastic Anemias

Leah Ann Schmelkin, BS, Matthew T Howard, MD, David P. Steensma, MD, Mark D. Fleming, MD DPhil, Vilmarie Rodriguez, MD, Shakila Khan, MD, Naseema Gangat, MBBS, Alexandra Wolanskyj, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 3355.

https://doi.org/10.1182/blood.V126.23.3355.3355

Published: 2015

Journal Articles

NPM1 +/ FLT3 - Patients with Acute Myeloid Leukemia (AML) Have Excellent Clinical Outcome Independent of Age When Treated with Cytotoxic Chemotherapy: Mayo Clinic Experience

Mehrdad Hefazi Torghabeh, MD, Mustaqeem A Siddiqui, MD, Mrinal M. Patnaik, MBBS, Alexandra Wolanskyj, MD, Darci Zblewski, CNP, Michelle Elliott, MD, William J Hogan, MD, Mark R. Litzow, MD, Aref Al-Kali, MD

Blood (2014) 124 (21): 5331.

https://doi.org/10.1182/blood.V124.21.5331.5331

Published: 2014

Journal Articles

Bi-Institutional Study of Etiology, Clinical Characteristics and Outcomes of Adult Patients with Hemophagocytic Lymphohistiocytosis

Zaher K. Otrock, MD, Alexandra Wolanskyj, MD, Charles S. Eby, MD, Roshini Abraham, PhD, Prashant Kapoor, MD, Sameer A. Parikh, MD

Blood (2014) 124 (21): 2724.

https://doi.org/10.1182/blood.V124.21.2724.2724

Published: 2014

Journal Articles

Management Of PICC-Associated Thrombosis In Patients Receiving Chemotherapy For Hematologic Malignancies

Meera Sridharan, MD, PhD, Aref Al-Kali, MD, Aneel A. Ashrani, MBBS, MSc, Kebede Begna, MD, Michelle Elliott, William J. Hogan, MBChB, Carl C. Hook, MD, Scott H. Kaufmann, MD, PhD, Louis Letendre, MD, Mark R. Litzow, MD, Mrinal M. Patnaik, MBBS, Animesh D. Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Alexandra Wolanskyj, MD, Rajiv K. Pruthi, MBBS

Blood (2013) 122 (21): 5000.

https://doi.org/10.1182/blood.V122.21.5000.5000

Published: 2013

Journal Articles

Treatment-Related AML Patients Previously Treated with Taxanes for Breast Cancer Have Similar Outcomes As De Novo AML

Lindsey E. Roeker, Alexandra Wolanskyj, MD, Michelle Elliott, William Hogan, MD, Mark Litzow, MD, Aref Al-Kali, MD

Blood (2012) 120 (21): 3555.

https://doi.org/10.1182/blood.V120.21.3555.3555

Published: 2012

Journal Articles

Loss of the Y Chromosome Predicts Lower Complete Cytogenetic Remission Rate in Patients (pts) with Chronic Myeloid Leukemia (CML)

Mohamed Abdelfatah, Adel Al-Alwan, Zeyad Kanaan, Mark R Litzow, MD, Alexandra Wolanskyj, Kebede Begna, William Hogan, MD, Daniel L. Van Dyke, Ph.D., Aref Al-Kali, MD

Blood (2012) 120 (21): 4804.

https://doi.org/10.1182/blood.V120.21.4804.4804

Published: 2012

Journal Articles

Outcome of Adult Patients with Hemophagocytic Syndrome: A Tertiary Care Center Experience

Sameer A. Parikh, MD, Prashant Kapoor, MD, Shaji K. Kumar, MD, Louis Letendre, MD, Alexandra Wolanskyj, MD

Blood (2012) 120 (21): 1040.

https://doi.org/10.1182/blood.V120.21.1040.1040

Published: 2012

Journal Articles

FLT3 Mutation Predicts Worse Clinical Outcome of Relapsed Acute Myeloid Leukemia (rAML) Patients (Pts): Mayo Clinic Experience.

Ahmed Elkhanany, Niamh Keane, Alexandra Wolanskyj, William Hogan, Michelle Elliott, Mark Litzow, MD, Aref Al-Kali, MD

Blood (2012) 120 (21): 2525.

https://doi.org/10.1182/blood.V120.21.2525.2525

Published: 2012

Journal Articles

Pruritus in Primary Myelofibrosis: Clinical and Laboratory Correlates

Brianna Vaa, Alexandra Wolanskyj, MD, Lindsey Roecker, Animesh Pardanani, MBBS, PhD, Terra L Lasho, MT, (ASCP), Christy Finke, BS, Ayalew Tefferi, MD

Blood (2011) 118 (21): 5154.

https://doi.org/10.1182/blood.V118.21.5154.5154

Published: 2011

Journal Articles

Lack of Efficacy of Pyridoxine (Vitamin B6) Treatment In Acquired Idiopathic Sideroblastic Anemia, Including Refractory Anemia with Ring Sideroblasts

Lisa M Baumann Kreuziger, MD, Alexandra Wolanskyj, MD, David P. Steensma, MD

Blood (2010) 116 (21): 2919.

https://doi.org/10.1182/blood.V116.21.2919.2919

Published: 2010

NARROW

Clinical, Molecular, and Prognostic Comparisons between Clonal Cytopenias of Undetermined Significance and Lower-Risk Myelodysplastic Syndromes - a Study of 184 Molecularly Annotated Patients

Spectrum of Abnormalities and Clonal Transformation in Germline RUNX1 Familial Platelet Disorder and a Comparative Analysis with Somatic RUNX1 Mutations in Myeloid Neoplasms

Desideromastica: Tactile Chew Cravings in Iron Deficiency Anemia

3,023 Mayo Clinic Patients with Myeloproliferative Neoplasms: Risk-Stratified Comparison of Survival and Outcomes Data Among Disease Subgroups

The Clinical Utility of Pharmacogenomics Testing in Assessing Tyrosine Kinase Inhibitor Therapy, Intolerance and Responses in Patients with Chronic Myelogenous Leukemia

Decreased Survival and Increased Rate of Fibrotic Progression in Essential Thrombocythemia Chronicled after the FDA Approval Date of Anagrelide

1,123 Consecutive Adults with Non-APL Acute Myeloid Leukemia: The Mayo Clinic Experience

Prognostic Impact of ASXL1 Mutations and Extent of Bone Marrow Dysplasia in Patients with Who - defined Myelodysplastic Syndrome with Ring Sideroblasts

Analysis of Serum Ferritin Levels As a Diagnostic Criteria for Hemophagocytic Lymphohistiocytosis (HLH) in Hospitalized Adult Patients

Survival Trends in Essential Thrombocythemia in the Face of Changing Treatment Practices

Clinico-Pathological Features and Outcomes in Patients with Congenital Sideroblastic Anemias

NPM1 +/ FLT3 - Patients with Acute Myeloid Leukemia (AML) Have Excellent Clinical Outcome Independent of Age When Treated with Cytotoxic Chemotherapy: Mayo Clinic Experience

Bi-Institutional Study of Etiology, Clinical Characteristics and Outcomes of Adult Patients with Hemophagocytic Lymphohistiocytosis

Management Of PICC-Associated Thrombosis In Patients Receiving Chemotherapy For Hematologic Malignancies

Treatment-Related AML Patients Previously Treated with Taxanes for Breast Cancer Have Similar Outcomes As De Novo AML

Loss of the Y Chromosome Predicts Lower Complete Cytogenetic Remission Rate in Patients (pts) with Chronic Myeloid Leukemia (CML)

Outcome of Adult Patients with Hemophagocytic Syndrome: A Tertiary Care Center Experience

FLT3 Mutation Predicts Worse Clinical Outcome of Relapsed Acute Myeloid Leukemia (rAML) Patients (Pts): Mayo Clinic Experience.

Pruritus in Primary Myelofibrosis: Clinical and Laboratory Correlates

Lack of Efficacy of Pyridoxine (Vitamin B6) Treatment In Acquired Idiopathic Sideroblastic Anemia, Including Refractory Anemia with Ring Sideroblasts

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only